Immune classification and identification of prognostic genes for uveal melanoma based on six immune cell signatures
Abstract Cutaneous melanoma could be treated by immunotherapy, which only has limited efficacy on uveal melanoma (UM). UM immunotyping for predicting immunotherapeutic responses and guiding immunotherapy should be better understood. This study identified molecular subtypes and key genetic markers as...
Guardado en:
Autores principales: | Guohong Gao, Zhilong Yu, Xiaoyan Zhao, Xinyi Fu, Shengsheng Liu, Shan Liang, Aijun Deng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6033d47f4ef2409f8231477417ba052d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Yan Zhang, et al.
Publicado: (2021) -
CARD11 is a prognostic biomarker and correlated with immune infiltrates in uveal melanoma.
por: Xueying Shi, et al.
Publicado: (2021) -
Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes
por: Han Zhao, et al.
Publicado: (2021) -
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Mizue Terai, et al.
Publicado: (2021) -
Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
por: Lu Zhang, et al.
Publicado: (2021)